References
- Torre LA , BrayF, SiegelRL, FerlayJ, Lortet-TieulentJ, JemalA. Global cancer statistics, 2012. CA Cancer J. Clin.65(2), 87–108 (2015).
- Chen W , SunK, ZhengRet al. Cancer incidence and mortality in China, 2014. Chin. J. Cancer Res.30(1), 1–12 (2018).
- Bozzetti F , MarianiL, Lo VulloSet al. The nutritional risk in oncology: a study of 1,453 cancer outpatients. Support Care Cancer20(8), 1919–1928 (2012).
- Heneghan HM , ZaborowskiA, FanningMet al. Prospective study of malabsorption and malnutrition after esophageal and gastric cancer surgery. Ann. Surg.262(5), 803–807; discussion 807–808 (2015).
- Bozzetti F , GroupSW. Screening the nutritional status in oncology: a preliminary report on 1,000 outpatients. Support Care Cancer17(3), 279–284 (2009).
- Rietveld SCM , Witvliet-Van NieropJE, Ottens-OussorenK, Van Der PeetDL, De Van Der SchuerenMAE. The prediction of deterioration of nutritional status during chemoradiation therapy in patients with esophageal cancer. Nutr. Cancer70(2), 229–235 (2018).
- Toyokawa T , KuboN, TamuraTet al. The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study. BMC Cancer16, 722 (2016).
- Van Cutsem E , ArendsJ. The causes and consequences of cancer-associated malnutrition. Eur. J. Oncol. Nurs.9(Suppl. 2), S51–S63 (2005).
- Clavier JB , AntoniD, AtlaniDet al. Baseline nutritional status is prognostic factor after definitive radiochemotherapy for esophageal cancer. Dis. Esophagus27(6), 560–567 (2014).
- Di Fiore F , LecleireS, PopDet al. Baseline nutritional status is predictive of response to treatment and survival in patients treated by definitive chemoradiotherapy for a locally advanced esophageal cancer. Am. J. Gastroenterol.102(11), 2557–2563 (2007).
- Cong MH , LiSL, ChengGWet al. An interdisciplinary nutrition support team improves clinical and hospitalized outcomes of esophageal cancer patients with concurrent chemoradiotherapy. Chin. Med. J.128(22), 3003–3007 (2015).
- Lyu JH , LiT, ZhuGYet al. Influence of enteral nutrition on nutritional status, treatment toxicities, and short-term outcomes in esophageal carcinoma patients treated with concurrent chemoradiotherapy: a prospective, multicenter, randomized controlled study (NCT 02399306). Chin. J. Radiat. Oncol.27(1), 44–48 (2018).
- Mak M , BellK, NgW, LeeM. Nutritional status, management and clinical outcomes in patients with esophageal and gastro-oesophageal cancers: a descriptive study. Nutr. Diet.74(3), 229–235 (2017).
- Odelli C , BurgessD, BatemanLet al. Nutrition support improves patient outcomes, treatment tolerance and admission characteristics in oesophageal cancer. Clin. Oncol. (R. Coll. Radiol.)17(8), 639–645 (2005).
- Cox S , PowellC, CarterB, HurtC, MukherjeeS, CrosbyTD. Role of nutritional status and intervention in oesophageal cancer treated with definitive chemoradiotherapy: outcomes from SCOPE1. Br. J. Cancer115(2), 172–177 (2016).
- Isenring E , EliaM. Which screening method is appropriate for older cancer patients at risk for malnutrition?Nutrition31(4), 594–597 (2015).
- Ye XJ , JiYB, MaBWet al. Comparison of three common nutritional screening tools with the new European Society for Clinical Nutrition and Metabolism (ESPEN) criteria for malnutrition among patients with geriatric gastrointestinal cancer: a prospective study in China. BMJ Open8(4), e019750 (2018).
- Orell-Kotikangas H , OsterlundP, SaarilahtiK, RavascoP, SchwabU, MakitieAA. NRS-2002 for pre-treatment nutritional risk screening and nutritional status assessment in head and neck cancer patients. Support Care Cancer23(6), 1495–1502 (2015).
- Guo XW , LiuYC, GaoFet al. Pretreatment NRS-2002 scores combined with hematologic inflammation markers are independent prognostic factors in patients with resectable thoracic esophageal squamous cell carcinoma. Cancer Manag. Res.10, 2409–2418 (2018).
- Arends J , BachmannP, BaracosVet al. ESPEN guidelines on nutrition in cancer patients. Clin. Nutr.36(1), 11–48 (2017).
- Pan P , TaoG, SunX. Subjective global assessment and prealbumin levels of esophageal cancer patients undergoing concurrent chemoradiotherapy. Nutr. Hosp.31(5), 2167–2173 (2015).
- Jager-Wittenaar H , OtteryFD. Assessing nutritional status in cancer: role of the Patient-generated Subjective Global Assessment. Curr. Opin. Clin. Nutr. Metab. Care20(5), 322–329 (2017).
- Isenring E , BauerJ, CapraS. The scored Patient-generated Subjective Global Assessment (PG-SGA) and its association with quality of life in ambulatory patients receiving radiotherapy. Eur. J. Clin. Nutr.57(2), 305–309 (2003).
- Ottery FD . Definition of standardized nutritional assessment and interventional pathways in oncology. Nutrition12(1 Suppl.), S15–S19 (1996).
- Persson C , SjodenPO, GlimeliusB. The Swedish version of the Patient-generated Subjective Global Assessment of nutritional status: gastrointestinal vs urological cancers. Clin. Nutr.18(2), 71–77 (1999).
- Quyen TC , AngkatavanichJ, ThuanTV, XuanVV, TuyenLD, TuDA. Nutrition assessment and its relationship with performance and Glasgow prognostic scores in Vietnamese patients with esophageal cancer. Asia Pac. J. Clin. Nutr.26(1), 49–58 (2017).
- Um MH , ChoiMY, LeeSM, LeeIJ, LeeCG, ParkYK. Intensive nutritional counseling improves PG-SGA scores and nutritional symptoms during and after radiotherapy in Korean cancer patients. Support Care Cancer22(11), 2997–3005 (2014).
- Shi HP , ZhaoQC, WangQHet al. Three stage diagnosis of malnutrition. Chin. J. Oncol. Prev. Treat7(5), 313–319 (2015).
- Isenring EA , BauerJD, CapraS. Nutrition support using the American Dietetic Association medical nutrition therapy protocol for radiation oncology patients improves dietary intake compared with standard practice. J. Am. Diet. Assoc.107(3), 404–412 (2007).
- Xu YJ , ChengJC, LeeJM, HuangPM, HuangGH, ChenCC. A walk-and-eat intervention improves outcomes for patients with esophageal cancer undergoing neoadjuvant chemoradiotherapy. Oncologist20(10), 1216–1222 (2015).
- Poulsen GM , PedersenLL, ØsterlindKet al. Randomized trial of the effects of individual nutritional counseling in cancer patients. Clin. Nutr.33(5), 749–753 (2014).
- Jordan T , MastnakDM, PalamarN, KozjekNR. Nutritional therapy for patients with esophageal cancer. Nutr. Cancer70(1), 23–29 (2018).
- Bozzetti F , ArendsJ, LundholmKet al. ESPEN Guidelines on Parenteral Nutrition: non-surgical oncology. Clin. Nutr.28(4), 445–454 (2009).
- Cong MH , ChengGW, Shu-LuanLI. The effect of tube feeding on esophageal cancer patients with concurrent chemo-radiotherapy. China Cancer23(12), 1029–1033 (2014).
- Miller KR , BozemanMC. Nutrition therapy issues in esophageal cancer. Curr. Gastroenterol. Rep.14(4), 356–366 (2012).
- Panagiotakis PH , DisarioJA, HildenK, OgaraM, FangJC. DPEJ tube placement prevents aspiration pneumonia in high-risk patients. Nutr. Clin. Pract.23(2), 172–175 (2008).
- Blomberg J , LagergrenJ, MartinL, MattssonF, LagergrenP. Complications after percutaneous endoscopic gastrostomy in a prospective study. Scand. J. Gastroenterol.47(6), 737–742 (2012).
- Keung EZ , LiuX, NuzhadA, RabinowitsG, PatelV. In-hospital and long-term outcomes after percutaneous endoscopic gastrostomy in patients with malignancy. J. Am. Coll. Surg.215(6), 777–786 (2012).
- National Comprehensive Cancer Network . NCCN Clinical Practice Guidelines in oncology: esophageal and esophagogastric junction cancers. V.1.2017 (2017). www.nccn.org/professionals/physician_gls/pdf/esophageal.pdf.
- Sousa AL , SousaD, VelascoF, AcucenaF, LopesA, GuerreiroH. Rare complication of percutaneous endoscopic gastrostomy: ostomy metastasis of esophageal carcinoma. World J. Gastrointest. Oncol.5(11), 204–206 (2013).
- Cappell MS . Risk factors and risk reduction of malignant seeding of the percutaneous endoscopic gastrostomy track from pharyngoesophageal malignancy: a review of all 44 known reported cases. Am. J. Gastroenterol.102(6), 1307–1311 (2007).
- Ellrichmann M , SergeevP, BethgeJet al. Prospective evaluation of malignant cell seeding after percutaneous endoscopic gastrostomy in patients with oropharyngeal/esophageal cancers. Endoscopy45(7), 526–531 (2013).
- Volkmer K , MeyerT, SailerM, FeinM. Implantation of an esophageal squamous cell carcinoma at the site of a percutaneous endoscopic gastrostomy. Endoscopy39(Suppl. 1), e240–e241 (2007).
- Pisano G , CalòPG, TattiAet al. Surgical gastrostomy when percutaneous endoscopic gastrostomy is not feasible: indications, results and comparison between the two procedures. Chir. Ital.60(2), 261–266 (2008).
- Mãodeferro S , SerranoM, FerreiraSet al. Stents in patients with esophageal cancer before chemoradiotherapy: high risk of complications and no impact on the nutritional status. Eur. J. Clin. Nutr.70(3), 409 (2015).
- Yu FJ , ShihHY, WuCYet al. Enteral nutrition and quality of life in patients undergoing chemoradiotherapy for esophageal carcinoma: a comparison of nasogastric tube, esophageal stent, and ostomy tube feeding. Gastrointest. Endosc.88(1), 21–31 e24 (2018).
- Jones CM , GriffithsEA. Should oesophageal stents be used before neo-adjuvant therapy to treat dysphagia in patients awaiting oesophagectomy? Best evidence topic (BET). Int. J. Surg.12(11), 1172–1180 (2014).
- Spaander MC , BaronTH, SiersemaPDet al. Esophageal stenting for benign and malignant disease: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy48(10), 939–948 (2016).
- Roza AM , ShizgalHM. The Harris Benedict equation reevaluated: resting energy requirements and the body cell mass. Am. J. Clin. Nutr.40(1), 168–182 (1984).
- Amirkalali B , HosseiniS, HeshmatR, LarijaniB. Comparison of Harris Benedict and Mifflin–St Jeor equations with indirect calorimetry in evaluating resting energy expenditure. Indian J. Med. Sci.62(7), 283–290 (2008).
- Wu J , HuangC, XiaoHet al. Weight loss and resting energy expenditure in male patients with newly diagnosed esophageal cancer. Nutrition29(11–12), 1310–1314 (2013).
- Ceolin Alves AL , ZuconiCP, CorreiaMI. Energy expenditure in patients with esophageal, gastric, and colorectal cancer. JPEN J. Parenter. Enteral. Nutr.40(4), 499–506 (2016).
- Langius JA , KruizengaHM, UitdehaagBMet al. Resting energy expenditure in head and neck cancer patients before and during radiotherapy. Clin. Nutr.31(4), 549–554 (2012).
- Rathmell JC , FoxCJ, PlasDR, HammermanPS, CinalliRM, ThompsonCB. Akt-directed glucose metabolism can prevent Bax conformation change and promote growth factor-independent survival. Mol. Cell Biol.23(20), 7315–7328 (2003).
- Han H , LiW, ShenH, ZhangJ, ZhuY, LiY. microRNA-129-5p, a c-Myc negative target, affects hepatocellular carcinoma progression by blocking the Warburg effect. J. Mol. Cell Biol. doi:10.1093/jmcb/mjw010 (2016) ( Epub ahead of print).
- Ho VW , LeungK, HsuAet al. A low carbohydrate, high protein diet slows tumor growth and prevents cancer initiation. Cancer Res.71(13), 4484–4493 (2011).
- Fietkau R , LewitzkiV, KuhntTet al. A disease-specific enteral nutrition formula improves nutritional status and functional performance in patients with head and neck and esophageal cancer undergoing chemoradiotherapy: results of a randomized, controlled, multicenter trial. Cancer119(18), 3343–3353 (2013).
- Minami Y , MiyataH, DokiYet al. Omega-3 fatty acid-containing diet (Racol) reduces toxicity of chemoradiation therapy for patients with esophageal cancer. Gan. To. Kagaku. Ryoho.35(3), 437–440 (2008).
- Cong M , SongC, ZouBet al. Impact of glutamine, eicosapntemacnioc acid, branched-chain amino acid supplements on nutritional status and treatment compliance of esophageal cancer patients on concurrent chemoradiotherapy and gastric cancer patients on chemotherapy. Zhonghua Yi Xue Za Zhi95(10), 766–769 (2015).
- Vasson MP , TalvasJ, PercheOet al. Immunonutrition improves functional capacities in head and neck and esophageal cancer patients undergoing radiochemotherapy: a randomized clinical trial. Clin. Nutr.33(2), 204–210 (2014).
- Sunpaweravong S , PuttawibulP, RuangsinSet al. Randomized study of antiinflammatory and immune-modulatory effects of enteral immunonutrition during concurrent chemoradiotherapy for esophageal cancer. Nutr. Cancer66(1), 1–5 (2014).
- De Aguiar Pastore Silva J , Emilia De Souza FabreM, WaitzbergDL. Omega-3 supplements for patients in chemotherapy and/or radiotherapy: a systematic review. Clin. Nutr.34(3), 359–366 (2015).
- Shi HP . Efficacy evaluation of nutrition therapy. Electron J. Metab. Nutr. Cancer4(4), 364–370 (2017).
- Gramlich L , HurtRT, JinJ, MundiMS. Home enteral nutrition: towards a standard of care. Nutrients10(8), 1020 (2018).
- Schattner M , BarreraR, NygardSet al. Clinical research: outcome of home enteral nutrition in patients with malignant dysphagia. Nutr. Clin. Pract.16(5), 292–295 (2001).
- Hebuterne X , BozzettiF, Moreno VillaresJMet al. Home enteral nutrition in adults: a European multicentre survey. Clin. Nutr.22(3), 261–266 (2003).
- Strollo BP , McClaveSA, MillerKR. Complications of home enteral nutrition: mechanical complications and access issues in the home setting. Nutr. Clin. Pract.32(6), 723–729 (2017).